- Report
- October 2023
- 178 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- May 2024
- 292 Pages
Global
From €5393EUR$5,600USD£4,638GBP
- Report
- February 2024
- 119 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- June 2023
- 260 Pages
Global
From €2311EUR$2,400USD£1,988GBP
- Report
- March 2024
- 188 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- March 2024
- 187 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- October 2023
- 171 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- November 2019
- 169 Pages
Global
From €1324EUR$1,375USD£1,139GBP
€2648EUR$2,750USD£2,278GBP
- Report
- November 2023
- 228 Pages
China
From €3852EUR$4,000USD£3,313GBP
- Report
- November 2023
- 118 Pages
China
From €1733EUR$1,800USD£1,491GBP
- Report
- February 2022
- 103 Pages
Global
From €3200EUR$3,560USD£2,848GBP
- Report
- November 2023
- 60 Pages
China
From €1733EUR$1,800USD£1,491GBP
- Report
- March 2020
- 107 Pages
Global
From €4334EUR$4,500USD£3,727GBP
- Book
- October 2020
Asia Pacific
The Pediatric Drugs market is a subset of the Pharmaceuticals industry, focusing on the development and distribution of drugs specifically designed for children. These drugs are tailored to the unique needs of pediatric patients, taking into account their smaller body size, different metabolism, and other physiological differences. Pediatric drugs are used to treat a wide range of conditions, from common illnesses to rare diseases.
The Pediatric Drugs market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of children. Additionally, the market is subject to the same pricing and reimbursement pressures as the broader Pharmaceuticals industry.
Notable companies in the Pediatric Drugs market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
